Science · 1984 · 113 citations · 10 references
MedicineNeurobiologyNeuroscienceCellular NeuroscienceNeurodegenerationNeuropharmacologyDevelopmental NeuropharmacologyDopaminergic PharmacologyNeural DevelopmentNeuronal DevelopmentNeuroprotectionNeurotransmissionDopaminergic NeurodegenerationDopaminergic NeuronsDopaminergic NeuroprotectionMonoamine Oxidase InhibitorsOrganotypic CultureOrganotypic Culture ModelsPhase-contrast MicroscopyTissue Explant Culture
Explants of embryonic rat mesencephalon were grown in organotypic culture. Addition of 10 microM 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to the culture medium for 4 to 7 days resulted in loss of dopamine cell bodies and fiber outgrowths, as observed by fluorescence histochemistry. At the same time, the cultures showed decreased uptake of tritium-labeled dopamine. However, no signs of generalized toxicity were evident when the explant cultures were viewed by light and phase-contrast microscopy. These results show that MPTP exerts a relatively selective destructive action in dopamine neurons in vitro, similar to the action observed in humans and monkeys in vivo. Pargyline (10 microM), a monoamine oxidase inhibitor, protected the dopamine neurons in the explants. Organotypic cultures provide an experimental model for the study of the properties of MPTP in vitro.
10
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
J. William Langston, Philip L. Ballard, James W. Tetrud et al. · Science · 1983 · 4.9K citations
Richard S. Burns, Chuang C. Chiueh, Sanford P. Markey et al. · Proceedings of the National Academy of Sciences · 1983 · 2.1K citations · Full text
Medicine, Neuroscience, Pharmacology +17
Chronic parkinsonism secondary to intravenous injection of meperidine analogues
Glenn C. Davis, Adrian Williams, Sanford P. Markey et al. · Psychiatry Research · 1979 · 1.4K citations
Medicine, Neurology, Pharmacology +16